Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 26/5/2017
SIETES contiene 91804 citas

 
 
 1 a 20 de 293 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Drugs for hypertension. The Medical Letter on Drug and Therapeutics Bulletin 2017;59:41-8. [Ref.ID 101527]
2.Enlace a cita original Cita con resumen
Hollingsworth JM, Canales BK, Rogers MAM, Sukumar S, Yan P, Kuntz GM, Dahm P. Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis. BMJ 2016;355:i6112. [Ref.ID 101017]
4.Enlace a cita original Cita con resumen
Page II RL, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, Spencer AP, Trupp RJ, Lindenfeld J, On behalf of the American Heart Association Clinical Pharmacology and Heart Failure and Trans- plantation Committees of the Council on Clini- cal Cardiology, Coun- cil on Cardiovascular Surgery and Anesthesia, Council on Cardio- vascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Drugs that may cause or exacerbate heart failure. A scientific statement from the American Heart Association. Circulation 2016;134:9 de agosto. [Ref.ID 100519]
5. Cita con resumen
Anónimo. Guanfacine for ADHD in children and adolescents. Drug Ther Bull 2016;54:56-60. [Ref.ID 100276]
6.Tiene citas relacionadas
Sternlicht H, Bakris GL. Spironolactone for resistant hypertension—hard to resist?. Lancet 2015;386:2032-4. [Ref.ID 99769]
7. Cita con resumen
Welk B, McArthur E, Fraser L-A, Hayward J, Dixon S, Hwang YJ, Ordon M. The risk of fall and fracture with the initiation of a prostate-selective a antagonist: a population based cohort study. BMJ 2015;351:h5398. [Ref.ID 99576]
8.Tiene citas relacionadas Cita con resumen
Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I, Cruickshank JK, Caulfield MJ, Salsbury J, Mackenzie I, Padmanabhan S, Brown MJ, for The British Hypertension Society's PATHWAY Studies Group. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet 2015;386:2059-68. [Ref.ID 99524]
9.Tiene citas relacionadas
Arrabal-Martín M, Cano-García MC. Tratamiento médico expulsivo de la litiasis ureteral con bloqueadores adrenérgicos alfa. Med Clin (Barc) 2015;145:251-2. [Ref.ID 99521]
10.Tiene citas relacionadas Cita con resumen
Benítez Camps M, Cerain Herrero MJ, de Miguel Llorente N, Martorell Sole E, Flores Mateo G, Pedro Pijoan AM, Murillo-Huapaya C. Eficacia y seguridad de tamsulosina para el tratamiento conservador del cólico nefrítico: revisión sistemática con metaanálisis de ensayos clínicos aleatorizados. Med Clin (Barc) 2015;145:239-47. [Ref.ID 99520]
11.Tiene citas relacionadas Cita con resumen
De la Rosette Jean, Laguna MP. Ureteric colic: evidence empowers responsible treatment. Lancet 2015;386:315-6. [Ref.ID 99393]
12. Cita con resumen
Anónimo. Incontinences urinaires d'origine médicamenteuse. Prescrire 2015;35:271-4. [Ref.ID 99126]
13.Tiene citas relacionadas Cita con resumen
Pickard R, Starr K, MacLennan G, Lam T, Thomas R, Burr J, McPherson G, McDonald A, Anson K, N'Dow J, Burgess N, Clark T, Kilonzo M, Gillies K, Shearer K, Boachie C, Cameron S, Norrie J, McClinton S. Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet 2015;386:341-9. [Ref.ID 99108]
14. Cita con resumen
Warlé-van Herwaarden MF, Valkhoff VE, Herings RMC, Engelkes M, van Blijderveen JC, Rodenburg EM, de Bie S, Alsma J, van de Steeg-Gompel C, Kramers C, Meyboom RHB, Sturkenboom MCJM, De Smet PAGM. Quick assessment of drug-related admissions over time (QUADRAT study). Pharmacoepidemiol Drug Saf 2015;24:495-503. [Ref.ID 98885]
16. Cita con resumen
Anónimo. Tadalafil (Cialis) et hypertrophie bénigne de la prostate. Prescrire 2013;33:886-7. [Ref.ID 96715]
19. Cita con resumen
Svensson S, Menkes DB, Lexchin J. Surrogate outcomes in clinical trials: a cautionary tale. JAMA Intern Med 2013;173:611-2. [Ref.ID 95286]
20. Cita con resumen
Ramírez E, Rossignoli T, Campos AJ, Muñoz R, Zegarra C, Tong H, Medrano N, Borobia AM, Carcas AJ, Frías J. Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signals . Eur J Clin Pharmacol 2013;69:97-110. [Ref.ID 94842]
Seleccionar todas
 
 1 a 20 de 293 siguiente >>